HCP

Hunt Capital Partners Transfers Ownership of 151-Unit Senior Property to Housing Authority of DeKalb County Affiliate

Retrieved on: 
Wednesday, March 13, 2024
Construction & Property, Seniors, Urban Planning, Professional Services, Socially Responsible Investing, Managed Care, Consumer, Health, Environmental, Social and Governance (ESG), Residential Building & Real Estate, ESG, Mental health, Clothing, Food, Housing authority, Housing, Investment, Partnership, Partner, HCP, Multimedia

On behalf of its investors, Hunt Capital Partners (“HCP”) has announced the ownership transfer of its Limited Partner interests in Ashford Parkside Senior Residences (Ashford Parkside) to a non-profit affiliate of the Housing Authority of DeKalb County.

Key Points: 
  • On behalf of its investors, Hunt Capital Partners (“HCP”) has announced the ownership transfer of its Limited Partner interests in Ashford Parkside Senior Residences (Ashford Parkside) to a non-profit affiliate of the Housing Authority of DeKalb County.
  • The strategic decision provides the Housing Authority of DeKalb County greater capital flexibility surrounding all aspects of property operations and repair projects as it shapes its long-term housing plan.
  • “We are pleased to transfer ownership of Ashford Parkside to an affiliate of the Housing Authority of DeKalb County,” said Hunt Capital Partners President Jeff Weiss.
  • The transfer of ownership of Ashford Parkside is a testament to Hunt Capital Partners and the Housing Authority of DeKalb County’s commitment to provide quality housing choices to meet the needs of Atlanta’s senior community.

Transforming Life Sciences Compliance: Baker Tilly Unveils Innovative HCP Engagement Solution

Retrieved on: 
Tuesday, March 12, 2024
Consulting, Data Management, Biotechnology, Accounting, Technology, Professional Services, Other Health, Health, Other Science, Software, Science, Risk, HCP, Growth, LLP, CPA

In a move set to redefine compliance processes within the life sciences industry, leading advisory CPA firm Baker Tilly US, LLP (Baker Tilly), introduces engagementNOW and transparencyNOW.

Key Points: 
  • In a move set to redefine compliance processes within the life sciences industry, leading advisory CPA firm Baker Tilly US, LLP (Baker Tilly), introduces engagementNOW and transparencyNOW.
  • These cutting-edge solutions aim to streamline engagement and reporting procedures for life sciences companies, irrespective of their size or global reach.
  • By integrating these products into the complianceNOW platform, Baker Tilly enables life sciences companies to simplify interactions with healthcare professionals (HCP), reducing manual efforts and enhancing compliance controls within their existing workflows.
  • “Baker Tilly’s complianceNOW platform enables life sciences leaders to confidently fulfill their operational duties by gaining access to embedded compliance and risk controls backed by a trusted brand that facilitates a more cohesive approach to their compliance function.”
    “With the launch of engagementNOW and transparencyNOW, Baker Tilly provides life sciences companies with a streamlined HCP engagement solution, enabling life sciences companies to have a more coordinated approach when interacting with healthcare professionals as well as an enhanced compliance solution that is able to scale with growth of their organization,” said Samantha Sutherland , Baker Tilly director, life sciences consulting.

iSono Health Applauded by Frost & Sullivan for Ensuring Patient Comfort and Safety and Providing Quality Imaging and Diagnosis with its iSono Health ATUSA

Retrieved on: 
Wednesday, April 3, 2024
Diagnosis, ROI, Frost, Consultant, Health, Patient, SAN, Tissue, Hospital, Health care, Acquisition, Mammography, Overalls, Google Images, ABUS, HCP, FDA, Medical imaging

SAN ANTONIO, April 3, 2024 /PRNewswire/ -- Recently, Frost & Sullivan assessed the breast ultrasound industry and, based on its findings, recognizes iSono Health with the 2023 United States New Product Innovation Award. The company is carving a new category for the automated breast ultrasound (ABUS) market. The iSono Health ABUS ATUSA is approved by the US Food and Drug Administration (FDA) and is the world's first automated, portable, and wearable three-dimensional (3D) breast ultrasound. The scanner attaches to a unique wearable accessory with intuitive software that automates image acquisition and analysis and does not require trained breast ultrasound technicians.

Key Points: 
  • iSono Health AI ABUS ATUSA enables precise and prompt screening, eliminates delays and the need for trained technicians, provides cost-effective imaging, and improves patient outcomes significantly.
  • The iSono Health ABUS ATUSA is approved by the US Food and Drug Administration (FDA) and is the world's first automated, portable, and wearable three-dimensional (3D) breast ultrasound.
  • Poornima Srinivasan, Consultant at Frost & Sullivan, observed, "iSono Health is revolutionizing the ABUS diagnostic imaging market with its wearable accessories and 3D image acquisition.
  • With its strong overall performance, iSono Health earned Frost & Sullivan's 2023 United States New Product Innovation Award in the breast ultrasound industry.

iSono Health Applauded by Frost & Sullivan for Ensuring Patient Comfort and Safety and Providing Quality Imaging and Diagnosis with its iSono Health ATUSA

Retrieved on: 
Wednesday, April 3, 2024
Diagnosis, ROI, Frost, Consultant, Health, Patient, SAN, Tissue, Hospital, Health care, Acquisition, Mammography, Overalls, Google Images, ABUS, HCP, FDA, Medical imaging

SAN ANTONIO, April 3, 2024 /PRNewswire/ -- Recently, Frost & Sullivan assessed the breast ultrasound industry and, based on its findings, recognizes iSono Health with the 2023 United States New Product Innovation Award. The company is carving a new category for the automated breast ultrasound (ABUS) market. The iSono Health ABUS ATUSA is approved by the US Food and Drug Administration (FDA) and is the world's first automated, portable, and wearable three-dimensional (3D) breast ultrasound. The scanner attaches to a unique wearable accessory with intuitive software that automates image acquisition and analysis and does not require trained breast ultrasound technicians.

Key Points: 
  • iSono Health AI ABUS ATUSA enables precise and prompt screening, eliminates delays and the need for trained technicians, provides cost-effective imaging, and improves patient outcomes significantly.
  • The iSono Health ABUS ATUSA is approved by the US Food and Drug Administration (FDA) and is the world's first automated, portable, and wearable three-dimensional (3D) breast ultrasound.
  • Poornima Srinivasan, Consultant at Frost & Sullivan, observed, "iSono Health is revolutionizing the ABUS diagnostic imaging market with its wearable accessories and 3D image acquisition.
  • With its strong overall performance, iSono Health earned Frost & Sullivan's 2023 United States New Product Innovation Award in the breast ultrasound industry.

Data360 announces strategic partnership with Throtle

Retrieved on: 
Wednesday, April 3, 2024
Partnership, Physician, Patient, HCP, DSPS, Privacy, Marketing

WILMINGTON, Del., April 3, 2024 /PRNewswire/ -- Data360, Inc. announces a strategic partnership with Throtle to provide a valuable service to healthcare advertisers seeking to improve digital activation while continuing to satisfy essential compliance requirements.

Key Points: 
  • WILMINGTON, Del., April 3, 2024 /PRNewswire/ -- Data360, Inc. announces a strategic partnership with Throtle to provide a valuable service to healthcare advertisers seeking to improve digital activation while continuing to satisfy essential compliance requirements.
  • In this partnership, Data360 will supply Throtle with an unparalleled breadth of data on physicians and healthcare professionals (HCPs) – more than 90 percent coverage of the entire HCP universe – that includes online audience identifiers plus intent-based behavior.
  • James J. Miller, President & CEO, Data360, Inc., says: "This collaboration underscores Data360's dedication to innovation in solution development and in nurturing partnerships with best-in-class leaders like Throtle.
  • "Throtle is committed to advancing healthcare marketing by providing secure and precise identity solutions," said Chris Neuner, President, Throtle.

Cloud Peritus Launches MedTech360°: Streamlining CRM Implementation in the MedTech Industry

Retrieved on: 
Tuesday, April 2, 2024
Cloud, CRM, DPN, Health, Salesforce, SAN, SVP, Patient, Marketing, Distributor, Salesforce Marketing Cloud, HCP, Medtech, Online shopping

SAN FRANCISCO, April 2, 2024 /PRNewswire/ -- In an industry as complex and dynamic as MedTech, finding solutions that simplify and accelerate CRM implementation processes is crucial.

Key Points: 
  • SAN FRANCISCO, April 2, 2024 /PRNewswire/ -- In an industry as complex and dynamic as MedTech, finding solutions that simplify and accelerate CRM implementation processes is crucial.
  • This solution is tailored to enhance the efficiency and effectiveness of CRM systems for MedTech companies.
  • MedTech360° is more than just an accelerator; it's a comprehensive strategy designed to streamline the often convoluted path to CRM optimization.
  • "We understand the intricacies of CRM implementation in the MedTech industry and have crafted this accelerator to not only address those challenges but to provide a clear path forward.

Doceree Expands Leadership Bench with Deepak Kandaswamy as SVP of Corporate Development & Strategy for Global Growth

Retrieved on: 
Tuesday, April 2, 2024
Organization, Growth, Business, Comcast, Strategic planning, Acquisition, University, SoftBank Group, Senior, MBA, Rutgers University, HCP, Sky, Marketing, Corporate development, David G. Booth, Advertising, Management

PARSIPPANY, N.J., April 2, 2024 /PRNewswire/ -- Doceree , the leading global healthcare marketing platform building unprecedented programmatic solutions for HCP marketing with proprietary data tools, appoints Deepak Kandaswamy as Senior Vice President, Corporate Development and Strategy.

Key Points: 
  • PARSIPPANY, N.J., April 2, 2024 /PRNewswire/ -- Doceree , the leading global healthcare marketing platform building unprecedented programmatic solutions for HCP marketing with proprietary data tools, appoints Deepak Kandaswamy as Senior Vice President, Corporate Development and Strategy.
  • This strategic appointment underscores the company's commitment to enhancing its M&A capabilities and fueling global expansion, evident in its remarkable 3X year-on-year revenue growth.
  • Deepak Kandaswamy brings to Doceree extensive experience spanning over a decade in Corporate Development and Strategy, having held pivotal roles in some of the world's leading media and advertising organizations.
  • Deepak Kandaswamy shared his excitement about his new role, "I am thrilled to be a part of the exceptional team at Doceree.

Verix Upgrades Platform with "GenAI Database Explorer," Providing Actionable Insights on Commercial Pharma Data

Retrieved on: 
Thursday, March 28, 2024
Database, Patient, NLP, LLM, Behavior, HCP, Machine learning, Gen, Sales

SANTA CLARA, Calif., March 28, 2024 /PRNewswire/ -- Verix, a leading  AI-powered pharmaceutical commercial operations enhancement platform provider, announced today the launch of its "GenAI Database Explorer," a capability designed to revolutionize the exploration of commercial pharmaceutical data. Integrated with Tovana, this capability enables users to explore data intuitively using natural language, marking a significant leap forward in making complex data insights more accessible.

Key Points: 
  • The new LLM-based capability allows pharmaceutical sales representatives and commercial teams to navigate complex data assets intuitively, using natural language, providing accessible and actionable insights for sales execution.
  • SANTA CLARA, Calif., March 28, 2024 /PRNewswire/ -- Verix , a leading  AI-powered pharmaceutical commercial operations enhancement platform provider, announced today the launch of its "GenAI Database Explorer," a capability designed to revolutionize the exploration of commercial pharmaceutical data.
  • Integrated with Tovana , this capability enables users to explore data intuitively using natural language, marking a significant leap forward in making complex data insights more accessible.
  • Verix's platform, Tovana, uses machine learning to derive insights from commercial data assets, for pharmaceutical sales teams.

The Considered Ramps Up Management Structure With String of Creative VP Hires Spanning Medical to Design

Retrieved on: 
Tuesday, March 26, 2024
Lynx, AstraZeneca, Science, Digital, Health, Novartis, Nature, Creative director, Creativity, Gold, HCP, Reality–virtuality continuum, Medicine

It was, in fact, the agency's groundbreaking approach, model and, of course, team, that attracted her to the VP Medical Director role.

Key Points: 
  • It was, in fact, the agency's groundbreaking approach, model and, of course, team, that attracted her to the VP Medical Director role.
  • "The Considered is committed to moving the needle in healthcare marketing by pushing boundaries wherever possible to engage and activate our audiences," she notes.
  • Nowadays, as Design Director, it's about setting the standards high by recognizing and showcasing what great design is."
  • The string of new VP hires at The Considered comes on the heels of several award wins for the agency.

Ngram Releases Groundbreaking AI Dataset to Revolutionize Medical Information Access for Healthcare Professionals

Retrieved on: 
Friday, March 22, 2024
Hugging Face, Drug, MIT, Patient, SAN, Information, Contraindication, Pharmacist, AI, MRDS, HCP, Data, Nursing, Medical device

SAN FRANCISCO, March 22, 2024 /PRNewswire-PRWeb/ -- Ngram, a San Francisco-based startup specializing in generative AI solutions for the life sciences industry, today announced the release of its innovative dataset, medchat-qa, on Hugging Face. This dataset comprises a blend of real-world and synthetic questions healthcare providers (HCPs) frequently ask pharmaceutical companies about their drugs. It covers critical topics such as dosage, adverse reactions, drug interactions, new indications, and off-label uses. The release of medchat-qa marks a significant step in Ngram's mission to simplify the process for Medical Affairs teams to swiftly access literature and deliver quick, precise responses to HCPs.

Key Points: 
  • Traditionally, doctors, nurses, pharmacists, and other HCPs seeking information about a drug must reach out to the pharmaceutical company's medical information department.
  • "HCPs require immediate access to accurate and current information to make informed treatment decisions," said Anish Muppalaneni, CEO and co-founder of Ngram.
  • "The medchat-qa dataset is a vital step toward fulfilling this objective and transforming how Medical Affairs teams deliver and access information for healthcare professionals."
  • The open-source release of the medchat-qa dataset on Hugging Face signifies a substantial progress in medical information access, highlighting Ngram's dedication to enhancing the healthcare experience for professionals and patients alike.